From the AGA Journals
From the Journals
Eradicating H. pylori may cut risk of gastric cancer
Treatment without eradication was associated with an increase in risk.
From the Journals
Optimal management of Barrett’s esophagus without high-grade dysplasia
A cost-effectiveness analysis finds that endoscopic eradication therapy is the optimal strategy for patients with low-grade dysplasia that has...
From the Journals
Long-term entecavir looks safe, effective in HBV
The entecavir and nonentecavir trial arms did not significantly differ in time-to-event analyses of malignant neoplasms, liver-related HBV disease...
From the Journals
Unique T cell populations pinpointed in hepatocellular carcinoma tissue
Cells identified in tumors could represent target of immunotherapy and serve as “prognostic indicator of therapy responsiveness,” according to...
Latest News
Gastric electrical stimulation device may improve refractory vomiting
However, gastric electrical stimulation did not significantly improve the coprimary endpoint of quality of life.
From the Journals
AGA releases update for endoscopic treatment of Barrett’s esophagus
The update offers best practice advice for a range of clinical scenarios based on published evidence.
From the Journals
AGA publishes clinical practice guidelines for gastric intestinal metaplasia
The guidelines are the first of their kind to be published in the United States.
From the AGA Journals
Fibrosis scoring systems have ‘modest’ predictive value in general population
For predicting severe liver disease, investigators say today’s scoring systems lack precision in unselected populations with low prevalence of...
From the Journals
UC: Tofacitinib tied to modest, reversible lipid increases, infrequent CV events
The observation period was still relatively short, however so longer-term data may be needed to more fully characterize lipid impact and...
From the AGA Journals
No clear-cut evidence of vedolizumab effect in retrospective study of primary sclerosing cholangitis
Cholestasis markers dropped in some, but not all, patients with primary sclerosing cholangitis and inflammatory bowel disease, though a...